Pediatricians are advocating for safe infant sleep practices, concerned by too many sudden unexplained infant deaths in recent years and a rise in bed-sharing among families with infants. According to UMass Medical School ...
Nov 5, 2014
0
0
A new food education project is using the increasingly popular escape room idea to teach children and adults about balanced diets.
Dec 11, 2019
0
3
Researchers from University of British Columbia, Emory University, and New York University published a new paper in the Journal of Marketing that investigates the relationship between branding and counter-marketing in the ...
Apr 16, 2021
0
2
A lawsuit says representatives of some of the nation's largest generic drug manufacturers used code words to collude with competitors to divvy up market share and coordinate price increases.
Jun 24, 2019
0
0
British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.
May 9, 2012
0
0
Opting in to data sharing should be the default practice during public health emergencies, such as the recent Ebola epidemic, and barriers to sharing data and findings should be removed to ensure those responding to the emergency ...
Jan 5, 2016
0
0
In recent years, the scientific community has seen a push for more findable, accessible, interoperable, and reusable (FAIR) neurophysiology data sharing. While certain measures have been put in place by institutions such ...
Nov 8, 2023
0
0
People of color and low-income residents of major cities are far less likely to use municipal bike sharing systems than their white and higher-income counterparts. But researchers at Portland State University say that situation ...
Jun 28, 2017
0
0
To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...
Oct 16, 2014
0
0
Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin and Herceptin. In a Policy Review in The Lancet Oncology, Y. Tony Yang, a professor ...
Dec 1, 2020
0
0
